By British lawmakers are open to the idea of easing restrictions on psychedelics such as psilocybin.
reported by Benzinga Labor MP Charlotte Nichols said that by supporting “the Royal Psychiatrists’ Association, the Campaign Against Life of Misery (CALM), the Conservative Drug Reform Group and several others”, “medical access to psilocybin adjunctive therapy” We started discussing the need for promoting their reforms.
Mr Nichols said it was time for the UK to change the schedule for using psilocybin under the country’s drug laws enacted 20 years ago.
“There are serious and substantial barriers to legitimate research associated with Schedule I regulations,” Nichols said. As Benzinga quoted. “Current legislation does not prevent scientific research with these agents, but it makes research significantly more difficult, time-consuming and expensive.”
Benzinga Details:
“She applied for a Home Office Schedule I license to be able to work with substances while researching psilocybin therapy for substance use disorders (SUD), and needed 20,000 to refurbish the lab to current standards. He gave the example of a researcher who realized that he had to invest pounds in. As with heroin, cocaine and methamphetamine, there are no similar restrictions. He blamed the “huge credibility gap” that currently exists.
Psychedelics have emerged as the centerpiece of drug reform movements around the world. Britain’s University of Exeter announced last month that it would offer the world’s first postgraduate qualification in psychedelics.
of Guardian report At the time, “Exeter University’s certificate firmly establishes psychedelics as an area of scientific importance in the UK”, and it “paved the way for clinical therapies that would be available within the next five years”. and some treatments are in the final stages.” It is in the clinical trial stage. ”
“The program will draw on Exeter’s world-leading psychedelic research and will be named ‘Psychedelics: Mind, Medicine and Culture’. It was presented at Breaking Convention, Europe’s largest psychedelic conference.” Guardian report. “The program will open up new possibilities for psychedelics, including healthcare professionals, therapists and those wishing to tap into the psychedelic healthcare market, which is projected to be worth £8.4 billion by 2028. Intended for all who are interested, the certificate covers a wide range of topics.” Education about existing psychedelic therapies and research in psychology, psychiatry, neuroscience, consciousness and metaphysics that psychedelics confer. Examine cultures that have used psychedelics over the centuries, including modules on philosophy such as Insights, and a discussion of decolonizing psychedelic research and practice, including anthropological studies. Students also learn practical skills such as therapeutic techniques and research skills. ”
Psychedelic research is blooming in the United States as well, and lawmakers are pushing for reform.
In Minnesota, legislators formed a so-called “Psychedelic Medicine Task Force” to “advise Congress on legal, medical and policy issues related to the legalization of psychedelic medicine in the state.”
The Task Force’s mandate includes “an understanding of the scientific literature on the therapeutic efficacy of psychedelic medicine in the treatment of mental health conditions, including depression, anxiety, post-traumatic stress disorder, bipolar disorder, and other mental health conditions. This includes looking into existing research. Medical conditions for which psychedelic drugs may be an effective treatment option. ”
Earlier this year, Oregon became the first state in the United States to legalize psilocybin for personal use by adults over the age of 21. Colorado decriminalized psychedelic drugs, including psilocybin, after Colorado voters approved a bill last year.
